News

WASHINGTON, DC – During a full committee markup , the House Energy and Commerce Committee advanced budget reconciliation language...

President Trump this week signed an executive order that revived a drug pricing policy, known as the “most favored nation” policy, that...

The White House issued an  executive order  (EO) on April 15 aimed at “Lowering Drug Prices by Once Again Putting Americans First.” The...

Many Congressional leaders and stakeholders continue to highlight the need for the PBM reforms. Representative Buddy Carter (R-GA)...

Representatives Mariannette Miller-Meeks, M.D. (R-IA), Nannette Barragan (D-CA), Nicole Malliotakis (R-NY), Brad Schneider (D-IL), Rick...

Senators Grassley and Cantwell Continue Efforts to Ensure Patients, Employers and Unions No Longer Overpay for Prescriptions Feb. 13,...

California Governor Gavin Newsom (D) has vetoed CA SB966 , legislation which would increase transparency and accountability of pharmacy...

The Federal Trade Commission last week filed a suit accusing the three largest pharmacy benefit managers, or PBMs, of using their market...

The Federal Trade Commission on July 9 issued its interim report on prescription drug middlemen known as pharmacy benefit managers or...

Bipartisan legislation will help lower seniors’ costs for prescription drugs Today, U.S. Senators Ron Wyden (D-OR) and Mike Crapo (R-ID)...

Momentum Continues Building in Support of PBM Reforms to Lower Prescription Drug Costs   The White House held a roundtable discussion...

The Centers for Medicare & Medicaid Services recently issued a letter  to pharmacy benefit managers (PBMs), Medicare Part D Plans,...

The Modernizing and Ensuring PBM Accountability Act will bring transparency and accountability to PBM practices that drive up...

The Senate Finance Committee announced a set of proposed policy solutions to address challenges in the prescription drug supply chain,...